Anthem Biosciences931.05
-19.65 (-2.07%)

Anthem Biosciences Share Price

931.05-19.65 (-2.07%)
+13.04% past 1 Year

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
32%14%26%15%
43%17%15%31%
---15%
33%25%21%22%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
ANTHEM
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,901.1₹456833 Cr37.7712.0762.82₹11479 Cr
9,180₹245426 Cr83.9134.04128.41₹2568 Cr
4,860.5₹187320 Cr85.8916.7297.06₹2163 Cr
1,130.6₹113217 Cr25.099.4262.53₹5040 Cr
1,381.1₹112212 Cr33.299.7757.87₹3879 Cr
1,851₹101155 Cr92.526.829.25₹889 Cr
2,122.1₹97626 Cr17.6630.95154.36₹5333 Cr
2,337₹96859 Cr47.4213.7571.08₹1913 Cr
1,162.9₹96406 Cr29.925.3263.99₹4196 Cr
1,658.4₹93614 Cr25.2217.9596.84₹3505 Cr
934.4₹53498 Cr92.892.1312.67₹592 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹418 Cr₹611 Cr₹423 Cr₹550 Cr₹540 Cr₹483 Cr₹498 Cr₹525 Cr₹339 Cr
₹25 Cr₹51 Cr₹34 Cr₹48 Cr₹23 Cr₹14 Cr₹24 Cr₹28 Cr₹19 Cr
₹443 Cr₹662 Cr₹457 Cr₹598 Cr₹563 Cr₹497 Cr₹522 Cr₹553 Cr₹358 Cr
₹298 Cr₹383 Cr₹300 Cr₹366 Cr₹375 Cr₹318 Cr₹359 Cr₹350 Cr₹236 Cr
₹175 Cr₹318 Cr₹191 Cr₹266 Cr₹214 Cr₹209 Cr₹184 Cr₹223 Cr₹140 Cr
₹89 L₹2 Cr₹35 L₹3 Cr₹2 Cr₹52 L₹3 Cr₹4 Cr₹4 Cr
₹145 Cr₹278 Cr₹130 Cr₹230 Cr₹186 Cr₹178 Cr₹161 Cr₹200 Cr₹118 Cr
₹120 Cr₹190 Cr₹93 Cr₹173 Cr₹136 Cr₹83 Cr₹124 Cr₹162 Cr₹82 Cr

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
₹112 Cr₹112 Cr₹112 Cr₹114 Cr₹9 Cr₹8 Cr₹8 Cr₹11 Cr₹13 Cr₹13 Cr₹13 Cr₹8 Cr
₹33 Cr₹34 Cr₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹2897 Cr₹2264 Cr₹1813 Cr₹1627 Cr₹1346 Cr₹693 Cr₹413 Cr₹213 Cr₹138 Cr₹89 Cr₹50 Cr₹30 Cr
₹2897 Cr₹2264 Cr₹1813 Cr₹1627 Cr₹1346 Cr₹693 Cr₹413 Cr₹213 Cr₹138 Cr₹89 Cr₹50 Cr₹30 Cr
₹3043 Cr₹2410 Cr₹1925 Cr₹1741 Cr₹1355 Cr₹701 Cr₹422 Cr₹223 Cr₹151 Cr₹102 Cr₹64 Cr₹38 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹11 L₹8 L₹4 L₹0
₹28 Cr₹47 Cr₹112 Cr₹96 Cr₹6 Cr₹20 Cr₹76 Cr₹124 Cr₹55 Cr₹20 Cr₹14 Cr₹14 Cr
₹0₹0₹0₹0₹0₹0₹20 Cr₹32 Cr₹28 Cr₹30 Cr₹32 Cr₹5 Cr
-₹27 Cr-₹18 Cr-₹41 Cr-₹25 Cr-₹16 Cr-₹14 Cr-₹12 Cr₹5 L-₹79 L₹1 Cr₹73 L-₹89 L
₹17 Cr₹17 Cr₹17 Cr₹8 Cr₹27 Cr₹20 Cr₹16 Cr₹0₹54 L₹1 Cr₹44 L₹87 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹37 L₹50 L₹32 L
₹16 Cr₹8 Cr₹7 Cr₹5 Cr₹5 Cr₹7 Cr₹7 Cr₹4 Cr₹3 Cr₹3 Cr₹1 Cr₹94 L
₹34 Cr₹54 Cr₹93 Cr₹85 Cr₹22 Cr₹34 Cr₹107 Cr₹160 Cr₹86 Cr₹57 Cr₹49 Cr₹21 Cr
₹75 Cr₹110 Cr₹101 Cr₹72 Cr₹65 Cr₹77 Cr₹58 Cr₹33 Cr₹26 Cr₹24 Cr₹29 Cr₹13 Cr
₹188 Cr₹146 Cr₹107 Cr₹54 Cr₹109 Cr₹102 Cr₹162 Cr₹53 Cr₹29 Cr₹12 Cr₹7 Cr₹6 Cr
₹4 Cr₹43 Cr₹121 Cr₹29 Cr₹30 Cr₹80 Cr₹26 Cr₹35 Cr₹37 Cr₹27 Cr₹29 Cr₹21 Cr
₹262 Cr₹186 Cr₹130 Cr₹124 Cr₹145 Cr₹97 Cr₹1 Cr₹5 Cr₹27 Cr₹13 Cr₹4 Cr₹3 Cr
₹530 Cr₹485 Cr₹459 Cr₹279 Cr₹349 Cr₹356 Cr₹247 Cr₹126 Cr₹119 Cr₹76 Cr₹69 Cr₹43 Cr
₹3606 Cr₹2949 Cr₹2477 Cr₹2105 Cr₹1726 Cr₹1091 Cr₹776 Cr₹510 Cr₹355 Cr₹235 Cr₹181 Cr₹102 Cr
₹90 Cr₹54 Cr₹250 Cr₹226 Cr₹6 Cr₹11 Cr₹8 Cr₹0₹0₹0₹9 Cr₹6 Cr
₹51 Cr₹109 Cr₹233 Cr₹125 Cr₹35 Cr₹100 Cr₹159 Cr₹191 Cr₹119 Cr₹77 Cr₹74 Cr₹40 Cr
₹1507 Cr₹1300 Cr₹996 Cr₹884 Cr₹703 Cr₹682 Cr₹567 Cr₹346 Cr₹153 Cr₹136 Cr₹123 Cr₹64 Cr
₹723 Cr₹595 Cr₹514 Cr₹435 Cr₹374 Cr₹321 Cr₹261 Cr₹88 Cr₹67 Cr₹45 Cr₹35 Cr₹27 Cr
₹783 Cr₹705 Cr₹483 Cr₹449 Cr₹329 Cr₹361 Cr₹306 Cr₹258 Cr₹86 Cr₹91 Cr₹87 Cr₹37 Cr
₹264 Cr₹297 Cr₹345 Cr₹164 Cr₹154 Cr₹19 Cr₹50 Cr₹43 Cr₹74 Cr₹22 Cr₹6 Cr₹17 Cr
₹342 Cr₹121 Cr₹13 Cr₹6 Cr₹4 Cr₹0₹0₹0₹0₹0₹0₹0
₹342 Cr₹121 Cr₹13 Cr₹6 Cr₹4 Cr₹0₹0₹0₹0₹0₹0₹0
₹50 Cr₹29 Cr₹35 Cr₹47 Cr₹22 Cr₹24 Cr₹17 Cr₹8 Cr₹13 Cr₹12 Cr₹9 Cr₹4 Cr
₹159 Cr₹150 Cr₹81 L₹59 L₹79 L₹27 L₹40 L₹5 Cr₹2 Cr₹3 Cr₹13 L₹9 L
₹1599 Cr₹1301 Cr₹875 Cr₹666 Cr₹510 Cr₹404 Cr₹373 Cr₹316 Cr₹176 Cr₹128 Cr₹102 Cr₹58 Cr
₹666 Cr₹312 Cr₹459 Cr₹493 Cr₹269 Cr₹209 Cr₹99 Cr₹27 Cr₹8 Cr₹2 Cr₹5 Cr₹0
₹125 Cr₹340 Cr₹211 Cr₹129 Cr₹58 Cr₹35 Cr₹125 Cr₹58 Cr₹47 Cr₹37 Cr₹31 Cr₹15 Cr
₹591 Cr₹450 Cr₹490 Cr₹274 Cr₹326 Cr₹255 Cr₹105 Cr₹74 Cr₹84 Cr₹57 Cr₹31 Cr₹10 Cr
₹275 Cr₹172 Cr₹184 Cr₹343 Cr₹349 Cr₹41 Cr₹22 Cr₹11 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr
₹7 Cr₹10 Cr₹3 Cr₹3 Cr₹10 Cr₹4 Cr₹5 Cr₹11 Cr₹8 Cr₹6 Cr₹86 L₹34 L
₹344 Cr₹362 Cr₹253 Cr₹196 Cr₹204 Cr₹143 Cr₹46 Cr₹13 Cr₹29 Cr₹4 Cr₹8 Cr₹16 Cr
₹2007 Cr₹1647 Cr₹1602 Cr₹1438 Cr₹1216 Cr₹687 Cr₹403 Cr₹194 Cr₹179 Cr₹107 Cr₹79 Cr₹43 Cr
₹1477 Cr₹1162 Cr₹1143 Cr₹1159 Cr₹867 Cr₹331 Cr₹156 Cr₹68 Cr₹61 Cr₹31 Cr₹10 Cr-₹20 L
₹3606 Cr₹2949 Cr₹2477 Cr₹2105 Cr₹1726 Cr₹1091 Cr₹776 Cr₹510 Cr₹355 Cr₹235 Cr₹181 Cr₹102 Cr
₹54₹42₹34₹31₹1,544₹827₹503₹264₹174₹116₹70₹50
₹54₹42₹34₹31₹24₹13₹8₹4₹3₹2₹1₹1

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
₹824 Cr₹657 Cr₹477 Cr₹497 Cr₹546 Cr₹366 Cr₹121 Cr₹0₹0₹0₹0₹0
₹85 Cr₹73 Cr₹45 Cr₹27 Cr₹49 Cr₹77 Cr₹76 Cr₹0₹0₹0₹0₹0
₹139 Cr-₹301 Cr-₹262 Cr-₹104 Cr-₹139 Cr-₹94 Cr₹14 Cr₹0₹0₹0₹0₹0
₹1048 Cr₹430 Cr₹260 Cr₹421 Cr₹456 Cr₹349 Cr₹211 Cr₹0₹0₹0₹0₹0
₹844 Cr₹271 Cr₹140 Cr₹306 Cr₹333 Cr₹278 Cr₹166 Cr₹0₹0₹0₹0₹0
-₹702 Cr-₹147 Cr-₹221 Cr-₹376 Cr-₹205 Cr-₹196 Cr-₹109 Cr₹0₹0₹0₹0₹0
-₹40 Cr-₹136 Cr-₹77 Cr₹64 Cr₹181 Cr-₹63 Cr-₹48 Cr₹0₹0₹0₹0₹0
₹103 Cr-₹12 Cr-₹158 Cr-₹6 Cr₹308 Cr₹18 Cr₹9 Cr₹0₹0₹0₹0₹0
₹172 Cr₹184 Cr₹343 Cr₹349 Cr₹41 Cr₹22 Cr₹14 Cr₹0₹0₹0₹0₹0
-₹27 L-₹41 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹275 Cr₹172 Cr₹184 Cr₹343 Cr₹349 Cr₹41 Cr₹22 Cr₹0₹0₹0₹0₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Anthem Biosciences Ltd Share Price Today

The Anthem Biosciences Ltd share price today is ₹940.00. During the trading session, the Anthem Biosciences Ltd share price opened at ₹940.00 and recorded an intraday high of ₹951.00 and a low of ₹933.55. Last closing price was ₹934.50. Over the past 52 weeks, the Anthem Biosciences Ltd share price has ranged between ₹579.15 and ₹952.80. The current Anthem Biosciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.